Stay updated on Guselkumab in Active PsA: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.

Latest updates to the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.4%
- Check30 days agoNo Change Detected
- Check37 days agoChange DetectedThe webpage has been updated to reflect new dates and locations, specifically changing from Poznań, Poland to Poznan, Poland, and updating the last update dates to early 2025. Additionally, there is a notice regarding heavy traffic affecting NLM-NCBI services.SummaryDifference0.7%
- Check44 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
- Check59 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check66 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.1%
- Check95 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
Stay in the know with updates to Guselkumab in Active PsA: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.